| Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder (NCT00790868) | Boston University Charles River Campus | 2008-04-01 |
| Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder (NCT00628979) | US Department of Veterans Affairs | 2008-03-01 |
| Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder) (NCT01376128) | GlaxoSmithKline | 2008-03-01 |
| Treatment of Social Phobia and Panic Disorder in Adults (NCT00619138) | Haukeland University Hospital | 2008-03-01 |
| A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients (NCT00619892) | Indiana University | 2008-02-01 |
| Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) (NCT00947570) | University of California, San Diego | 2007-10-01 |
| Special Investigation Of Long Term Use Of Sertraline. (NCT00605813) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-09-01 |
| Evaluating the Effects of Stress in Pregnancy (NCT00525226) | Emory University | 2007-09-01 |
| Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD (NCT00579280) | University of South Florida | 2007-07-01 |
| Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents (NCT00535964) | University of Arkansas, Fayetteville | 2007-06-01 |
| Physical Exercise Versus Cognitive-behavioral Therapy (CBT) for Panic Disorders: A Randomised Controlled Trial (NCT01076777) | University of Bergen | 2007-05-01 |
| Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse (NCT00776685) | King's College London | 2007-05-01 |
| Special Investigation Of J Zoloft For Panic Disorder Patients (NCT00605917) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-04-01 |
| Drug Use Investigation of Jzoloft. (NCT00605865) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-04-01 |
| Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder (NCT00767871) | Samsung Medical Center | 2007-03-01 |
| Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder (NCT00767754) | Samsung Medical Center | 2007-01-01 |
| Study of Brain Circuitry in Anxiety Disorders (NCT01849432) | Mclean Hospital | 2006-12-01 |
| Comparison of Psychotherapy Programs to Treat Panic Disorder (NCT00353470) | Weill Medical College of Cornell University | 2006-09-01 |
| The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder (NCT00438971) | Massachusetts General Hospital | 2006-08-01 |
| Primary Care Intervention Strategy for Anxiety Disorders (NCT00347269) | University of Washington | 2006-06-01 |
| ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment (NCT00322803) | elbion AG | 2006-05-01 |
| Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day) (NCT01371474) | GlaxoSmithKline | 2006-04-01 |
| Cognitive Behavioral Therapy in Panic Disorder (NCT00772746) | Universidade Federal do Rio de Janeiro | 2006-03-01 |
| Treatment of Late-life Anxiety in Primary Care Settings (NCT00938093) | Wake Forest University Health Sciences | 2006-03-01 |
| Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety (NCT00352469) | Creighton University | 2006-02-01 |
| Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks (NCT00279617) | Lindner Center of HOPE | 2006-01-01 |
| Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy (NCT00515996) | Samsung Medical Center | 2006-01-01 |
| Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain (NCT00736346) | Université du Québec a Montréal | 2005-10-01 |
| Aripiprazole for the Treatment of Refractory Anxiety (NCT00438386) | Massachusetts General Hospital | 2005-04-01 |
| Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia (NCT00576719) | Boston University Charles River Campus | 2005-03-01 |
| Breathing Regulation Training for Individuals With Panic Disorder (NCT00183521) | Stanford University | 2005-03-01 |
| Neurobiological Mechanisms in Panic Disorder (NCT00103987) | National Institute of Mental Health (NIMH) | 2005-02-14 |
| Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder (NCT00845260) | Karolinska Institutet | 2004-12-01 |
| Augmenting Exposure Therapy With an N-Methyl-D-Aspartate (NMDA) Agonist for Panic Disorder (NCT00131339) | Hartford Hospital | 2004-11-01 |
| Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ (NCT00088738) | National Institute of Mental Health (NIMH) | 2004-07-27 |
| A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder (NCT00635076) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-07-01 |
| Genetic Causes of Panic Disorder (NCT00083265) | National Institute of Mental Health (NIMH) | 2004-05-13 |
| A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks (NCT00634790) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-05-01 |
| A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder (NCT00635531) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2004-04-01 |
| Telephone-Based Care Management Program for Individuals With Anxiety Disorders (NCT00158327) | University of Pittsburgh | 2004-03-01 |
| Levetiracetam for the Treatment of Alcohol Dependence and Anxiety (NCT00141115) | New York State Psychiatric Institute | 2004-03-01 |
| Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia (NCT00129610) | Hospices Civils de Lyon | 2004-01-01 |
| A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder Patients (NCT00198094) | Indiana University | 2003-12-01 |
| Personality-targeted Interventions for Adolescent Alcohol Misuse (NCT00344474) | King's College London | 2003-11-01 |
| A Study of Risperidone Monotherapy in Bipolar Anxiety (NCT00167479) | University of South Florida | 2003-09-01 |
| Efficacy of Treatment for Panic Disorder (NCT00456768) | University of British Columbia | 2003-05-01 |
| Risperidone vs. Paroxetine for Panic Attacks (NCT00206765) | Beth Israel Medical Center | 2003-01-01 |
| Therapy for Depression With Co-occurring Panic or Anxiety Symptoms (NCT00051207) | University of Pittsburgh | 2002-11-01 |
| Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders (NCT00182533) | Hamilton Health Sciences Corporation | 2002-07-01 |
| Panic Disorder and Cardiac Risk (NCT00168506) | Baker Heart Research Institute | 2002-06-01 |
| A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks (NCT00457106) | Beth Israel Medical Center | 2002-06-01 |
| Interactive Computer Treatment for Panic Disorder (NCT00063375) | Florida State University | 2002-01-01 |
| Ventilatory Physiology in Children at Risk for Anxiety (NCT00101777) | National Institute of Mental Health (NIMH) | 2001-12-01 |
| Study Evaluating Venlafaxine ER in Patients With Panic Disorder (NCT00044772) | Wyeth is now a wholly owned subsidiary of Pfizer | 2001-11-01 |
| Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder (NCT00025974) | National Institute of Mental Health (NIMH) | 2001-10-31 |
| Paroxetine vs Placebo Combined With Aerobic Exercise or Relaxation in Panic Disorder (NCT00540098) | University of Göttingen | 2001-09-01 |
| Study Evaluating Venlafaxine ER in Adults With Panic Disorder (NCT00038896) | Wyeth is now a wholly owned subsidiary of Pfizer | 2001-04-01 |
| Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders (NCT00102427) | University of Pittsburgh | 2000-07-01 |
| Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia (NCT00004367) | National Center for Research Resources (NCRR) | 2000-05-01 |
| Psychodynamic Therapy for Treating Panic Disorder (NCT00128388) | Weill Medical College of Cornell University | 2000-02-01 |
| Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine (NCT02852577) | Universidade Federal do Rio de Janeiro | 2000-01-01 |
| Therapies for Treatment-Resistant Panic Disorder Symptoms (NCT00118417) | Massachusetts General Hospital | 1999-03-01 |
| Treatment of Panic Disorder: Long Term Strategies (NCT00000368) | New York State Psychiatric Institute | 1999-02-01 |
| Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder (NCT00705380) | Boston University Charles River Campus | 1998-07-01 |
| Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder (NCT00004834) | Northwell Health | 1998-05-01 |
| Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety (NCT00004373) | National Institute on Drug Abuse (NIDA) | 1997-03-01 |
| Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction (NCT00004366) | National Center for Research Resources (NCRR) | 1995-08-01 |
| Costs of Lost Productive Time Among Korean Workers With Panic Disorder and Effect of Treatment With Paroxetine Controlled Release (NCT00492414) | Inje University | |